PBYI
Puma Biotechnology, Inc.
9.80$
+3.3%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 23.7% | 33.7% | 24.5% | 22.6% | 36.1% | 23.6% | 22.9% | 23.5% | 22.3% | 30.7% | 23.3% | 22.1% | 25.2% | |
| 76.3% | 66.3% | 75.5% | 77.4% | 63.9% | 76.4% | 77.1% | 76.5% | 77.7% | 69.3% | 76.7% | 77.9% | 74.8% | |
| 20.4% | 17.8% | 31.0% | 29.0% | 15.6% | 25.7% | 30.1% | 29.5% | 29.2% | 22.3% | 44.2% | 33.4% | 30.9% | |
| 39.5% | 27.5% | 49.4% | 53.4% | 20.9% | 28.8% | 37.8% | 35.1% | 31.3% | 24.4% | 41.1% | 31.1% | 30.9% | |
| 61.0% | 45.8% | 80.7% | 82.0% | 36.5% | 53.8% | 68.4% | 63.9% | 60.1% | 46.7% | 85.3% | 64.5% | 61.7% | |
| 15.3% | 20.5% | -5.3% | -4.6% | 27.4% | 22.6% | 8.7% | 12.7% | 17.6% | 22.7% | -8.5% | 13.4% | 13.2% | |
| 6.0% | 4.6% | 7.7% | 7.2% | 3.8% | 4.4% | 4.7% | 3.5% | 2.7% | 1.5% | 1.6% | 0.3% | 1.5% | |
| 10.7% | 17.7% | -10.5% | -8.8% | 25.6% | 20.7% | 7.1% | 11.8% | 17.0% | 22.7% | -7.6% | 14.6% | 13.5% | |
| 0.4% | 0.7% | 0.5% | 0.8% | 0.4% | -12.0% | 0.6% | 0.6% | 0.7% | 4.9% | 0.7% | 0.1% | 1.9% | |
| 10.3% | 17.0% | -11.0% | -9.6% | 25.2% | 32.7% | 6.5% | 11.2% | 16.2% | 17.8% | -8.4% | 14.5% | 11.6% | |
| 21.8% | 25.4% | 3.8% | 4.5% | 33.0% | 30.0% | 17.9% | 20.5% | 24.7% | 27.7% | -0.4% | 23.9% | 20.6% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.